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Abstract
Background: Acute acalculous cholecystitis (AAC) is a relatively rare disorder of the gallbladder. Breast cancer
recurrence more than 10 years after curative surgery is also infrequent.
Case presentation: Here, we report a case of a 59-year-old woman who presented with right flank pain. Her
medical history included a lumpectomy for cancer of the left breast 12 years prior. Laboratory tests showed a
severe inflammatory reaction and mild liver function abnormalities. Ultrasonography and computed tomography
revealed an enlarged gallbladder and inflammation of the surrounding tissues; however, no gallstone was present.
She was diagnosed with AAC. We performed an emergency laparoscopic cholecystectomy, and histopathological
examination revealed a poorly differentiated adenocarcinoma in the cystic duct. Both metastatic and primary tumor
cells were positive for estrogen and progesterone receptors on immunohistochemistry. The final pathological
diagnosis was acute cholecystitis due to breast cancer metastasis to the cystic duct.
Conclusion: Although AAC secondary to metastatic breast cancer is rare, it should be included in the differential
diagnosis for abdominal pain in patients with a previous history of breast cancer.
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Background
Acute acalculous cholecystitis (AAC) is characterized by
gallbladder inflammation without cystic duct obstruction
due to gallstones. It is clinically indistinguishable from
acute calculous cholecystitis (ACC). AAC accounts for
2–12 % of acute cholecystitis cases [1–3]. Most cases of
AAC are related to surgery, total parental nutrition, and
prolonged fasting [4, 5]; AAC caused by metastases to
the gallbladder is relatively infrequent [6].
Breast cancer has a high recurrence rate, and recur-
rences tend to occur within 5 years of surgery. Recur-
rences after more than 10 years of disease-free survival
are rare, although they are still commoner than in other
cancers such as colon and gastric cancer [7–9].
We report a case of AAC secondary to metastatic
breast cancer. This was discovered incidentally after
cholecystectomy in a patient who had 12 years of
disease-free survival.
Case presentation
A 59-year-old woman presented to our hospital complain-
ing of right flank and epigastric pain. An examination of
the abdomen revealed tenderness in the right upper quad-
rant and positive Murphy’s sign. Her laboratory test re-
sults were as follows: white blood cell count, 13,600/mm3;
hemoglobin, 8.2 g/dL; platelet count, 20.6 × 104/mm3; as-
partate aminotransferase, 45 IU/L; alanine aminotransfer-
ase, 61 IU/L; total bilirubin, 1.0 mg/dL; and C-reactive
protein, 26.2 mg/dL. The levels of carcinoembryonic anti-
gen (CEA) and carbohydrate antigen 19-9 were 6.3 ng/mL
and 224.9 U/mL, respectively. Abdominal ultrasonography
(US) revealed a thickened gallbladder wall and subserosal
edema. Computed tomography (CT) also revealed an en-
larged gallbladder and pericholescystic fluid collection
(Fig. 1b). However, stones were not observed in the gall-
bladder or cystic duct, and the cause of the acute chole-
cystitis could not be identified. Drip-infusion
cholangiography-CT (DIC-CT) confirmed the lack of pa-
tency of the cystic duct and showed no gallstones in the
common bile duct (Fig. 1c).
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The patient’s medical history included a lumpectomy
of invasive ductal carcinoma of the left breast and nega-
tive sentinel lymph node (pT1c/pN0) 12 years before.
She had been followed up with US, CT, and fluorine-18-
fluorodeoxyglucose positron-emission tomography
(FDG-PET) imaging for 10 years, and no recurrence had
been observed as of her last follow-up.
The patient was diagnosed with AAC and underwent a
laparoscopic cholecystectomy without any complications.
Macroscopically, the gallbladder mucosa appeared nec-
rotic. Histopathological examination revealed a poorly
differentiated adenocarcinoma in the cystic duct and gall-
bladder neck. On immunohistochemical examination, the
tumor cells were positive for estrogen and progesterone
receptors (ER and PR). The tumor cells were also positive
for cytokeratin-7 and epithelial membrane antigen and
were negative for human epidermal growth factor receptor
2 (HER2), gross cystic disease fluid protein-15, and
cytokeratin-20. These results were similar to the immuno-
histochemical findings from the primary breast cancer
(Fig. 2f). Accordingly, the pathological diagnosis of meta-
static breast cancer was made. One month after cholecyst-
ectomy, an FDG-PET scan revealed abdominal para-aortic
lymph node metastases and a lumbar vertebra metastasis.
The patient was treated with chemotherapy and hormone
therapy, and she died 5 years later (17 years later after
breast surgery).
Discussion
AAC is associated with a higher mortality rate and has a
worse prognosis than ACC [4, 10, 11]. Most cases of
AAC occurs in critically ill patients and are related to
surgery, burns, severe trauma, bacterial sepsis, shock,
congestive heart failure, total parenteral nutrition, and
prolonged fasting [4, 5]. AAC is also associated with
gallbladder cancer and bile duct cancer [12, 13]. Ida et
al. reported a 6.9 % incidence of AAC in gallbladder can-
cer [14]. In contrast, cystic duct cancer is extremely rare
and is not usually diagnosed prior to cholecystectomy
[15]. Thickening of the gallbladder neck and cystic duct
walls in the context of AAC can suggest the presence of
cancer. Endoscopic ultrasonography and cytodiagnosis
from endoscopic naso-gallbladder drainage may be use-
ful in identifying this thickening [16–18].
Metastasis to the gallbladder is very rare. Metastases ori-
ginating from malignant melanomas, and lung, renal, pan-
creatic, and colorectal cancers have been reported [6, 19].
Breast cancer metastasis to the gallbladder is rare and our
literature search revealed only 25 cases. Only one case of
cystic duct metastasis had been reported [20]. In this case,
cystic duct metastasis occurred after metastases to both
lobes of the liver, and right-supraclavicular node, which
was found 3 years after mastectomy. Acalculous cholecyst-
itis was indicated based on the clinical finding of obstruc-
tion of the cystic duct by liver metastasis. Laparotomy
Fig. 1 a US showed thickening of the gallbladder wall and subserosal edema. b CT showed the enlarged gallbladder and the thickened
gallbladder wall. c DIC-CT showed no gallstones in the common bile duct and an interruption of cystic duct
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revealed a solitary metastatic deposit surrounding the
proximal cystic duct. In our case, prior to the cholecystec-
tomy, the suspicion of breast cancer metastasis to the
cystic duct was low because the patient had remained
cancer-free for over 10 years.
Breast cancer is the commonest form of malignancy in
females. Postoperative recurrence occurs in approxi-
mately 30 % of cases [21]. The commonest sites of re-
currence are the bone, lung, and liver [7–9]. Owing to
advances in chemotherapy and endocrine therapy, the
prognosis for breast cancer has improved over the years.
Despite this, many patients continue to experience dis-
ease recurrence. Recurrences tend to occur within the
first 5 years after surgery; late recurrences after more
than 10 years are very uncommon [7, 9, 22]. Late recur-
rences have been found to affect the bone and lung in
33.3 % of patients, and the recurrence patterns of late
and early recurrences were not found to be significantly
different [22]. Lymph node metastases [23], ER-positive
status [9], and HER2-negative status [24] are reported to
be risk factors for late recurrence in breast cancer pa-
tients. In our case, the patient’s tumor cells were positive
for ER and PR and negative for HER2 on immunohisto-
chemical examination. Moreover, it was recently re-
ported that extension of hormonal treatment to 10 years
was useful for preventing recurrences in such patients
Fig. 2 a Macroscopically, the gallbladder mucosa was necrotic and black. The cystic duct and gallbladder bladder were thickened and white. b
Microscopic examination revealed a poorly differentiated adenocarcinoma in the cystic duct. Scale bar is 50 μm. c Immunohistochemical
examination revealed that the tumor cells were positive for ER. Scale bar is 50 μm. d The primary breast cancer was an invasive ductal carcinoma.
Scale bar is 50 μm. e Immunohistochemical examination revealed that the tumor cells of the primary breast cancer were positive for ER. Scale bar
is 50 μm. f Comparison between metastatic tumor cells (cystic duct) and primary breast cancer cells on immunohistochemical examination
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[25]. On the other hand, post-relapse survival was sig-
nificantly longer in patients with late recurrences than in
patients with early recurrences [26, 27]. In the present
case, after multiple metastases were diagnosed, the pa-
tient was treated with aromatase inhibitor therapy,
bisphosphonate therapy, and chemotherapy such as pac-
litaxel and epirubicin, and she survived for 5 years.
In this patient, even if her breast cancer metastases
were diagnosed before cholecystectomy, this knowledge
might not have been useful in guiding the clinical
decision-making process because multiple metastases
were detected on FDG-PET only 2 weeks after the sur-
gery. However, most cases of late breast cancer recur-
rence involve solitary tumors, which can be radically
treated to improve patient survival [28]. As such, it is
important to be able to identify AAC due to metastases
from breast cancer recurrence prior to surgery.
Conclusions
In conclusion, we have reported a case of AAC secondary
to cystic duct metastasis from recurrent breast cancer. It
is necessary to consider metastatic breast cancer as a
cause of AAC in patients with a history of breast cancer.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images.
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